These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3816973)

  • 21. Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom.
    Hoshino M; Yanaihara C; Hong YM; Kishida S; Katsumaru Y; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J; Yanaihara N
    FEBS Lett; 1984 Dec; 178(2):233-9. PubMed ID: 6439576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of Gila monster venom with VIP receptors in intestinal epithelium of human. A comparison with rat.
    Amiranoff B; Vauclin-Jacques N; Boige N; Rouyer-Fessard C; Laburthe M
    FEBS Lett; 1983 Dec; 164(2):299-302. PubMed ID: 6317454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide.
    Itoh H; Lederis KP; Rorstad OP
    Eur J Pharmacol; 1990 Jun; 181(3):199-205. PubMed ID: 2384132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus?
    D'Amato M; Currò D; Ciabattoni G; Lefebvre RA
    Arch Int Pharmacodyn Ther; 1990; 303():216-31. PubMed ID: 1973609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of peptide histidine isoleucine in non-adrenergic non-cholinergic relaxation of the rat gastric fundus induced by high-frequency neuronal firing.
    Currò D; De Marco T; Preziosi P
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):578-86. PubMed ID: 12444500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man.
    Lundberg JM; Fahrenkrug J; Hökfelt T; Martling CR; Larsson O; Tatemoto K; Anggård A
    Peptides; 1984; 5(3):593-606. PubMed ID: 6382200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4.
    Conroy DM; Samhoun MN; Piper PJ
    Br J Pharmacol; 1991 Dec; 104(4):1012-8. PubMed ID: 1725762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) on bronchoconstriction in guinea pigs].
    Aoki S; Kurosawa M; Ishizuka T; Mori M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Nov; 30(11):1946-50. PubMed ID: 1484433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells.
    Murthy KS; Zhang KM; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):G660-71. PubMed ID: 7694477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroidogenic effect of peptide histidine-isoleucine (PHI) in vitro: comparison with VIP.
    Nowak KW; Malendowicz LK
    Endocr Res; 1998; 24(3-4):759-62. PubMed ID: 9888573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.
    Griffiths NM; Simmons NL; Rivier J
    Pflugers Arch; 1989 Jun; 414(2):222-7. PubMed ID: 2755776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excitatory actions of peptide histidine isoleucine on thalamic relay neurons.
    Lee SH; Cox CL
    Neuropharmacology; 2008 Dec; 55(8):1329-39. PubMed ID: 18804119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vasoactive intestinal polypeptide on isolated urethral and urinary bladder smooth muscle from rabbit and man.
    Sjögren C; Andersson KE; Mattiasson A
    J Urol; 1985 Jan; 133(1):136-40. PubMed ID: 2981104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for VIP-induced increase in NO production in myenteric neurons of opossum internal anal sphincter.
    Chakder S; Rattan S
    Am J Physiol; 1996 Mar; 270(3 Pt 1):G492-7. PubMed ID: 8638716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries.
    Greenberg B; Rhoden K; Barnes PJ
    Blood Vessels; 1987; 24(1-2):45-50. PubMed ID: 3567364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
    Mikkelsen JD; Fahrenkrug J
    Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.